Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06187064 · ClinicalTrials.gov registry record · NA

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT06187064: Completed NA study, sponsored by University of Washington.

NCT06187064 is a NA study that has completed, run by University of Washington. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06187064, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Seattle. The pop-up clinic will be housed within a van and serve as a research extension of the SHE Clinic, a Harborview Medical Center run clinic for women who exchange sex and use drugs in north Seattle. Through the implementation of the pop-up clinic, the investigators will aim to assess: 1. The impact of the pop-up clinic on uptake and sustained use of HIV pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) among WWID. 2. The impact of point of care (POC) sexually transmitted infection (STI) testing on STI treatment completion rates. 3. The acceptability and feasibility of providing HIV prevention care for WWID and exchange sex in a pop-up van clinic.

Primary Outcome

Proportion of participants who initiate PrEP

Interventions

  • OTHER Mobile Van Clinic

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-03-18
Est. Completion 2025-03-12
Phase NA
University of Washington

1,048 total trials

What the finished NCT06187064 record still lists

NCT06187064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Mobile Van Clinic is the first listed.

NCT06187064 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06187064 about?

NCT06187064 is a clinical study titled "Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington". The investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Seattle. The pop-up clinic will be housed within a van and serve as a research extension of the SHE Cl...

What is the current status of trial NCT06187064?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-18. Estimated completion is 2025-03-12.

What interventions are being tested in trial NCT06187064?

The interventions under investigation include: Mobile Van Clinic (OTHER).

Who is sponsoring clinical trial NCT06187064?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06187064's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06187064, the US trial registry maintained by the National Library of Medicine. NCT06187064 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.